Esophagogastroduodenoscopy-assisted bowel preparation for colonoscopy

Table 1 Baseline characteristics of subjects (%)

	EGD-assisted(n = 42)	Conventional-PEG(n = 40)
Age [median (range (IQR)]	73 [42-99 (19.25)]	73.5 [45-97 (17.5)]
Males/females	15/27	20/20
Bleeding as indication for EGD	28 (67)	33 (83)
Diabetes mellitus	12 (29)	13 (33)
Congestive heart failure	11 (26)	10 (25)
Stroke	10 (24)	4 (10)
Azotemia	16 (38)	10 (25)
Opiate/anticholinergic medications	16 (38)	13 (33)

EGD: Esophagogastroduodenoscopy; IQR: Inter-quartile range.

Table 2 Symptom profiles of esophagogastroduodenoscopy-assisted/conventional-polyethylene glycol subjects¹

Symptom	None	Mild	Moderate	Severe	Intolerable	P value
Bloating	26/21	8/9	3/1	1/2	0/0	0.83252
Dizzy	37/30	1/4	0/0	0/0	0/0	0.12802
Nausea	30/18	7/10	0/6	0/1	1/0	0.00502
Vomiting	35/30	2/2	0/1	0/1	0/0	0.33592
Pain	28/21	8/12	1/1	1/0	0/0	0.27882
Poor sleep	22/13	9/8	11/9	0/3	0/1	0.19152
Taste	8/4	27/20	2/9	1/2	0/0	0.01762
Complete	Yes 35/29	No 3/6	-	-	-	0.29633
Other prep	Yes 10/21	No 28/14	-	-	-	0.00473
Refuse	Yes 1/5	No 37/30	-	-	-	0.09823

¹Values in each cell denote number of esophagogastroduodenoscopy-assisted/conventional-polyethylene glycol subjects; small numbers of subjects in certain categories were pooled as necessary to satisfy criteria for statistical analysis;

²χ² test for trend;

³Fisher’s exact test; bolded P values denote statistical significance.